About
Revelation Biosciences Inc (NASDAQ:REVB) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 26 2026
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
Jan 26 2026
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
Jan 23 2026
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
Jan 21 2026
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
Jan 14 2026
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
Financials
Revenue
$0
Market Cap
$4.65 M
EPS
-23.95
Translate